PL373522A1 - Nowe związki kwasu askorbinowego, sposoby ich syntezy i ich zastosowania - Google Patents

Nowe związki kwasu askorbinowego, sposoby ich syntezy i ich zastosowania

Info

Publication number: PL373522A1
Authority: PL; Poland
Prior art keywords: synthesis; methods; ascorbic acid; acid compounds; application use
Prior art date: 2001-08-24

Application number

PL02373522A

Other languages

English (en)

Inventor

Matthias Rath

Aleksandra Niedzwiecki

Vadim Ivanov

Shrirang Netke

M.Waheed Roomi

Original Assignee

Matthias Rath

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-24

Filing date

2002-08-23

Publication date

2005-09-05

2002-08-23 Application filed by Matthias Rath filed Critical Matthias Rath

2005-09-05 Publication of PL373522A1 publication Critical patent/PL373522A1/pl

Links

125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 title 1
230000015572 biosynthetic process Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)

PL02373522A 2001-08-24 2002-08-23 Nowe związki kwasu askorbinowego, sposoby ich syntezy i ich zastosowania PL373522A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US31485701P	2001-08-24	2001-08-24

Publications (1)

Publication Number	Publication Date
PL373522A1 true PL373522A1 (pl)	2005-09-05

Family

ID=23221754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02373522A PL373522A1 (pl)	2001-08-24	2002-08-23	Nowe związki kwasu askorbinowego, sposoby ich syntezy i ich zastosowania

Country Status (19)

Country	Link
US (2)	US6864284B2 (pl)
EP (3)	EP2241560A3 (pl)
JP (1)	JP4162593B2 (pl)
KR (1)	KR20040044472A (pl)
CN (3)	CN100361987C (pl)
BR (1)	BR0205944A (pl)
CA (1)	CA2458344A1 (pl)
HR (1)	HRP20040207A2 (pl)
HU (1)	HUP0600084A2 (pl)
IL (4)	IL155578A0 (pl)
MX (1)	MXPA04001655A (pl)
NO (1)	NO20031844L (pl)
NZ (3)	NZ531430A (pl)
PL (1)	PL373522A1 (pl)
RU (1)	RU2309152C2 (pl)
UA (1)	UA78223C2 (pl)
WO (2)	WO2003018000A1 (pl)
YU (1)	YU38103A (pl)
ZA (1)	ZA200304712B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040067890A1 (en) *	2002-10-04	2004-04-08	Gupta Shyam K.	Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions
AU2004232556A1 (en) *	2003-04-21	2004-11-04	Tagra Biotechnologies Ltd.	Stabilized derivatives of ascorbic acid
CN100346782C (zh) *	2004-05-21	2007-11-07	北京京卫信康医药科技发展有限公司	一种含氨基酸的维生素c组合物
KR100544159B1 (ko) *	2004-07-14	2006-01-24	센양 뉴라이프 인더스트리알 코 엘티디	아스코르빌 테트라이소팔미테이트와 디팔미토일하이드록시프롤린을 함유한 나노 에멀젼 및 이를함유하는 화장료 조성물
US20070002866A1 (en) *	2005-06-29	2007-01-04	Denso Corporation	Receive power priority flooding in mobile ad hoc networks
WO2007098467A2 (en)	2006-02-21	2007-08-30	Mary Kay, Inc.	Stable vitamin c compositions
US20080188553A1 (en) *	2007-02-06	2008-08-07	Waheed M Roomi	Novel ascorbic acid compounds, methods of synthesis and application use thereof
FR2913686B1 (fr) *	2007-03-14	2009-05-01	Oreal	Nouveaux composes carbamates de vitamine c, compositions les comprenant, et utilisations
US8828960B2 (en) *	2007-07-17	2014-09-09	Idexx Laboratories, Inc.	Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
WO2018005762A2 (en) *	2016-06-29	2018-01-04	Orasis Medical, Inc.	Ascorbic acid-amino acid conjugates and their use in regulation of fluid outflow
US11629169B2 (en) *	2017-09-15	2023-04-18	Kine Sciences Co., Ltd.	Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1273989A (fr) *	1960-09-09	1961-10-20	Marbou	Procédé de préparation de l'ascorbate de lysine
US4424232A (en) *	1982-05-19	1984-01-03	Parkinson Richard W	Treatment of herpes simplex
US4518614A (en) *	1982-11-04	1985-05-21	Redken Laboratories, Inc.	Cosmetic preparation
JPS63190882A (ja)	1987-02-03	1988-08-08	Nippon Haipotsukusu:Kk	アスコルビン酸誘導体及びそれを含有する皮膚脱色剤並びにその製造法
DE68928488T2 (de) *	1988-09-19	1998-04-02	Oxycal Lab Inc	Zusammensetzungen und verabreichungsverfahren für heilmittel
FR2650180B1 (fr) *	1989-07-31	1995-03-03	Chisso Corp	Procede de production d'une feuille facilement soluble dans l'eau a base d'acide hyaluronique ou de hyaluronate et feuille ainsi obtenue
WO1991019488A1 (en) *	1990-06-04	1991-12-26	Therapy 2000	REDUCTION OF CARDIOVASCULAR VESSEL OCCLUSIONS WITH ASCORBATE AND LIPOPROTEIN (a) BINDING INHIBITORS
JPH04247011A (ja)	1991-02-04	1992-09-03	Q P Corp	リン脂質系アスコルビン酸誘導体及び該誘導体を含む皮膚外用剤
US5977073A (en) *	1991-06-06	1999-11-02	Life Sciences' Technologies, Inc.	Nutrient composition for treatment of immune disorders
JPH0666958A (ja) *	1991-08-29	1994-03-11	Masaki Yoshigaki	目覚し時計の目覚し設定並びに目覚し音停止機構
JPH0678560A (ja)	1992-08-26	1994-03-18	Matsushita Electric Works Ltd	インバータ装置
FR2715156B1 (fr)	1994-01-20	1996-03-01	Oreal	Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
US5626883A (en) *	1994-04-15	1997-05-06	Metagenics, Inc.	Ascorbic acid compositions providing enhanced human immune system activity
FR2732221B1 (fr) *	1995-03-28	1997-04-25	Oreal	Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
US5951990A (en)	1995-05-15	1999-09-14	Avon Products, Inc.	Ascorbyl-phosphoryl-cholesterol
US5607968A (en)	1995-06-07	1997-03-04	Avon Products, Inc.	Topical alkyl-2-O-L-ascorbyl-phosphates
FR2737971B1 (fr)	1995-08-25	1997-11-14	Lvmh Rech	Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
US6162419A (en)	1996-11-26	2000-12-19	Nicholas V. Perricone	Stabilized ascorbyl compositions
US5962517A (en) *	1997-01-31	1999-10-05	Murad; Howard	Pharmaceutical compositions and methods for treating acne
EP0891771A1 (en) *	1997-07-08	1999-01-20	Health Now, Inc.	Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases

2002
- 2002-08-23 ZA ZA200304712A patent/ZA200304712B/en unknown
- 2002-08-23 IL IL15557802A patent/IL155578A0/xx not_active IP Right Cessation
- 2002-08-23 HR HR20040207A patent/HRP20040207A2/hr not_active Application Discontinuation
- 2002-08-23 EP EP10006654.7A patent/EP2241560A3/en not_active Withdrawn
- 2002-08-23 CN CNB2005101136885A patent/CN100361987C/zh not_active Expired - Fee Related
- 2002-08-23 KR KR10-2004-7002629A patent/KR20040044472A/ko not_active Ceased
- 2002-08-23 JP JP2003523231A patent/JP4162593B2/ja not_active Expired - Fee Related
- 2002-08-23 NZ NZ531430A patent/NZ531430A/en unknown
- 2002-08-23 PL PL02373522A patent/PL373522A1/pl unknown
- 2002-08-23 NZ NZ542240A patent/NZ542240A/en unknown
- 2002-08-23 RU RU2004108687/04A patent/RU2309152C2/ru not_active IP Right Cessation
- 2002-08-23 UA UA2004032169A patent/UA78223C2/uk unknown
- 2002-08-23 MX MXPA04001655A patent/MXPA04001655A/es active IP Right Grant
- 2002-08-23 HU HU0600084A patent/HUP0600084A2/hu unknown
- 2002-08-23 CA CA002458344A patent/CA2458344A1/en not_active Abandoned
- 2002-08-23 US US10/226,588 patent/US6864284B2/en not_active Expired - Fee Related
- 2002-08-23 CN CNB028030184A patent/CN100360514C/zh not_active Expired - Fee Related
- 2002-08-23 WO PCT/US2002/027060 patent/WO2003018000A1/en not_active Ceased
- 2002-08-23 CN CNB2005101136870A patent/CN100378087C/zh not_active Expired - Fee Related
- 2002-08-23 EP EP02772197A patent/EP1423375A2/en not_active Withdrawn
- 2002-08-23 BR BR0205944-4A patent/BR0205944A/pt not_active IP Right Cessation
- 2002-08-23 YU YU38103A patent/YU38103A/sh unknown
- 2002-08-23 EP EP10006653.9A patent/EP2241559A3/en not_active Withdrawn
- 2002-08-23 NZ NZ542241A patent/NZ542241A/en unknown
- 2002-08-23 WO PCT/EP2002/009451 patent/WO2003018568A2/en not_active Ceased
2003
- 2003-04-24 IL IL155578A patent/IL155578A/en unknown
- 2003-04-24 IL IL176524A patent/IL176524A0/en unknown
- 2003-04-24 NO NO20031844A patent/NO20031844L/no not_active Application Discontinuation
2004
- 2004-02-18 US US10/781,296 patent/US7230124B2/en not_active Expired - Fee Related
2006
- 2006-06-22 IL IL176523A patent/IL176523A0/en unknown

Also Published As

Publication number	Publication date
UA78223C2 (uk)	2007-03-15
EP2241560A2 (en)	2010-10-20
NZ542240A (en)	2006-09-29
IL155578A (en)	2006-12-10
US6864284B2 (en)	2005-03-08
HUP0600084A2 (en)	2006-06-28
IL176523A0 (en)	2006-10-05
JP4162593B2 (ja)	2008-10-08
EP2241559A2 (en)	2010-10-20
EP1423375A2 (en)	2004-06-02
NZ531430A (en)	2006-05-26
US20040167077A1 (en)	2004-08-26
NZ542241A (en)	2006-09-29
MXPA04001655A (es)	2004-05-31
RU2309152C2 (ru)	2007-10-27
CN1763027A (zh)	2006-04-26
NO20031844D0 (no)	2003-04-24
EP2241559A3 (en)	2014-07-09
EP2241560A3 (en)	2014-07-09
CA2458344A1 (en)	2003-03-06
KR20040044472A (ko)	2004-05-28
HRP20040207A2 (en)	2005-02-28
CN100378087C (zh)	2008-04-02
US7230124B2 (en)	2007-06-12
WO2003018568A3 (en)	2003-12-04
YU38103A (sh)	2006-05-25
IL155578A0 (en)	2003-11-23
WO2003018000A1 (en)	2003-03-06
JP2005501867A (ja)	2005-01-20
CN1518545A (zh)	2004-08-04
CN100361987C (zh)	2008-01-16
WO2003018568A2 (en)	2003-03-06
US20030119753A1 (en)	2003-06-26
CN1763028A (zh)	2006-04-26
CN100360514C (zh)	2008-01-09
ZA200304712B (en)	2004-07-12
NO20031844L (no)	2003-06-12
RU2004108687A (ru)	2005-09-20
IL176524A0 (en)	2006-10-05
BR0205944A (pt)	2004-12-28

Publication	Publication Date	Title
TWI318201B (en)	2009-12-11	Novel succinate salt of o-desmethyl-venlafaxine
AU2002363236A1 (en)	2003-05-12	Compounds, pharmaceutical compositions and methods of use therefor
IL190218A0 (en)	2008-11-03	Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2002224927A1 (en)	2002-06-24	Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AUPR879601A0 (en)	2001-12-06	Novel chemical compounds and their use
HUP0402616A3 (en)	2009-01-28	Biphenylmethyl-thiazolidinedones, biphenyl-propionic acid derivatives, their use as ppar-gamma activators and pharmaceutical and cosmetic compositions containing them
AU2002346548A8 (en)	2003-06-23	Regioisomerically pure oxochlorins and methods of synthesis
MXPA03006403A (es)	2003-10-15	Sintesis de la temozolomida y analogos.
ZA200500203B (en)	2009-09-30	Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2003275056A8 (en)	2004-04-08	Novel lapacho compounds and methods of use thereof
IL155578A0 (en)	2003-11-23	Novel ascorbic acid compounds, methods of synthesis and application use thereof
MXPA03006402A (es)	2003-10-15	Sintesis de temozolomida y analogos.
AU2003274202A8 (en)	2004-02-25	Novel difluorinated gem compounds, preparation methods thereof and applications of same
HUP0500734A3 (en)	2005-12-28	Use of 2-alkoxyphenyl-substituted imidazotriazinones
AUPR879701A0 (en)	2001-12-06	Novel chemical compounds and their use
AU2002246926A1 (en)	2002-08-06	12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU4450100A (en)	2000-10-23	225Ac-heha and related compounds, methods of synthesis and methods of use
IL161608A0 (en)	2004-09-27	Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
AU2002323394A1 (en)	2003-03-10	Novel ascorbic acid compounds, methods of synthesis and application
IL161642A0 (en)	2004-09-27	IMPROVED PURIFICATION OF 4,4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
IL155259A0 (en)	2003-11-23	New derivatives of cyano-aryl) or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
AU2002315767A1 (en)	2003-01-21	Novel aliphatic compounds, synthesis method and method of using the same
GB0109520D0 (en)	2001-06-06	Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors
TW530768U (en)	2003-05-01	Novel structure of stationery set
SI1448564T1 (sl)	2006-08-31	Substituirane indolizinu podobne spojine in postopki uporabe